Investor Connect 904: Functional Precision Oncology with Dr. Christian Apfel of SageMedic
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
On this episode of Investor Connect, Hall welcomes Dr. Christian Apfel, founder at Sage Medic. SageMedic is advancing functional precision oncology through its core platform, the Sage OncoTest, which uses a patient's live tumor tissue to create 3D micro-tumors and test therapies directly against the tumor's biology to generate a sensitivity and resistance profile across chemotherapies and targeted therapies, including dose-response and both cytotoxicity and anti-proliferation effects.
Christian Apfel is a licensed physician, clinical researcher, life sciences investor, and entrepreneur with more than 100 publications, including work in the New England Journal of Medicine, and he previously led a clinical outcomes research group at UCSF. He shares how his father's lung cancer experience and low response-rate realities in standard care drove him to pursue functional testing, why genomic matching often falls short (including NCI MATCH results and sub-50% response even with targetable mutations), and how adoption, guidelines, reimbursement lag, CLIA/LDT readiness, MRD testing, and a planned Series A1 trial strategy shape the path to broader clinical use, with resources at sagemedic.com.
Visit SageMedic at www.sagemedic.com
Reach out to at www.linkedin.com/in/chrisapfel, and on capfel@sagemedic.com
________________________________________________________________________
For more episodes from Investor Connect, please visit the site at: http://investorconnect.org
Check out our other podcasts here: https://investorconnect.org/
For Investors check out: https://tencapital.group/investor-landing/
For Startups check out: https://tencapital.group/company-landing/
For eGuides check out: https:/_/tencapital.group/education/
For upcoming Events, check out https://tencapital.group/events/
For Feedback please contact info@tencapital.group
Please follow, share, and leave a review.
Music courtesy of Bensound.